O4 Development and validation of dimethylarginines (DAS) as a novel biomarker to identify pre-ACLF and predict outcomes following acute decompensation of cirrhosis in two prospective multicentre European cohorts
Year: 2025
Type: conference-abstract
Authors: Kohilan Gananandan, Peter Holland-Fischer, Karen Louise Thomsen, Konstantin Kazankov, Rohit Sawhney, Olivia Greenham, Steve Masson, Guru Aithal, Dan Forton, Kate Nash, Graham Foster, Cristina Sanchez, Anna Bosch, Augustin Albillos, Wim Laleman, Salvatore Piano, Javier Fernandez, Paolo Careceni, Thierry Gustot, Carlo Alessandra, Joan Clria, Richard Moreau, Paolo Angeli, Vincente Arroyo, Jonel Trebicka, Rajiv Jalan, Rajeshwar Mookerjee
Institutions: University College London, Aalborg University Hospital, Aarhus University Hospital, Eastern Health, Monash University, Freeman Hospital, Queen's Medical Centre, St George's Hospital, Southampton General Hospital, Queen Mary University of London, European Foundation for the Study of Chronic Liver Failure, Hospital Universitario Ramón y Cajal, Universitair Ziekenhuis Leuven, University of Padua, Hospital Clínic de Barcelona, University of Bologna, Université Libre de Bruxelles, University of Turin, University Hospital Münster
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414969871
Cites:
Cited by:
Related to: